X4 Pharmaceuticals Inc (XFOR) earnings · rev $6.5M
These earnings events as JSON? API free 100/dayX4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
This XFOR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported XFOR revenue for 2025-12-31 was $6.5M. Net income was -$79.2M. Revenue was up 150.0% from 2024-12-31 to 2025-12-31. XFOR currently screens at market cap $382.0M.
When the next XFOR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 150.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full XFOR research stays on the stock page; the tape stays on the quote page.
XFOR earnings FAQ
What are XFOR's latest revenue and net income?
Latest cached X4 Pharmaceuticals Inc (XFOR) revenue for Dec 31, 2025 was $6.5M. Net income was -$79.2M. Statements: https://lician.com/financials/xfor
What is XFOR's latest diluted EPS?
Latest cached X4 Pharmaceuticals Inc (XFOR) diluted EPS for Dec 31, 2025 was -$1.87.
What period does the latest XFOR earnings print cover?
The latest cached X4 Pharmaceuticals Inc (XFOR) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did XFOR revenue change from the prior cached period?
Cached X4 Pharmaceuticals Inc (XFOR) revenue was up 150.0% from $2.6M (Dec 31, 2024) to $6.5M (Dec 31, 2025). Statements: https://lician.com/financials/xfor
Where are XFOR earnings listed?
Cached earnings facts for X4 Pharmaceuticals Inc (XFOR) are listed at https://lician.com/earnings/xfor. Statements: https://lician.com/financials/xfor
Not investment advice.